您的位置: 首页 > 2022年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

影响先天性甲状腺功能减低症不同转归的早期因素

The early factors influencing different outcomes of congenital hypothyroidism

来源期刊: 广州医药 | 84-89 发布时间:2022-10-11 收稿时间:2025/11/13 18:18:06 阅读量:15
作者:
关键词:
先天性甲状腺功能减低症影响因素促甲状腺素转归
congenital hypothyroidisminfluencing factorsthyroid stimulating hormoneoutcome
DOI:
10.3969/j.issn.1000-8535.2022.05.017
收稿时间:
2021-08-05 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨影响先天性甲状腺功能减低症患儿不同转归的早期因素。 方法 选取2013年12月—2017年3月期间在本中心筛查并确诊的先天性甲状腺功能减低症患儿共80例,经左旋甲状腺激素钠治疗2~3年后停药评估再随访1年以上者,根据疾病转归将患儿分为持续性甲低组(29例)与暂时性甲低组(51例)。对2组患儿的临床情况进行回顾性分析,寻求影响结局的早期因素。结果 持续性甲低与暂时性甲低患儿初筛促甲状腺激素值[ 63.89 (43.89, 114.25) vs 38.54 (27.27, 60.00) mIU/L]、促甲状腺激素恢复正常所需剂量[(4.29±1.46) vs (3.38±1.34) μg/(kg·d)]、早期甲状腺超声正常比例[58.6%(17/29)vs 90.2%(46/51)]差异有统计学意义(P<0.05)。其中初筛促甲状腺激素值(最佳临界值:37.825 mIU/L,AUC=0.745,灵敏度0.897,特异度0.490)和出生后第8个月左旋甲状腺激素钠给药剂量[最佳临界值3.38 μg/(kg·d),AUC=0.759,灵敏度 0.586,特异度 0.843]可早期区别持续性甲低与暂时性甲低患儿。结论 初筛促甲状腺激素值和出生后左旋甲状腺激素钠给药剂量对先天性甲状腺功能减低症患儿临床转归有早期预测作用。
Objective To investigate the early factors affecting different outcomes of children with congenital hypothyroidism (CH). Methods A total of 80 children with CH screened and diagnosed at Meizhou Maternal and Child Health Care and Family Planning Service Center between December 2013 and March 2017, who were treated with levothyroxine sodium for 2~3 years and then discontinued for assessment and followed up for over 1 year, were selected and divided into the permanent CH group (29 cases) and transient CH group (51 cases) according to disease outcomes. The clinical conditions of the children were retrospectively analysed to seek early factors affecting outcome. Results The initial screening thyroid hormone values [ 63.89 (43.89, 114.25) vs 38.54 (27.27, 60.00) mIU/L ], the required dose to restore normal thyroid hormone in permanent and transient CH group [(4.29±1.46) vs (3.38±1.34) μg/(kg·d)], and the proportion of early normal thyroid ultrasound [58.6% (17/29) vs 90.2% (46/51)] had significant differences(P<0.05). The initial screening thyroid hormone value (optimal threshold: 37.825 mIU/L, AUC=0.745, sensitivity 0.897 and specificity 0.490) and the levothyroxine sodium dosage at eighth month of age [optimal threshold 3.38 μg/(kg·d), AUC=0.759, sensitivity 0.586 and specificity 0.843] could early distinguish permanent and transient CH children. Conclusions Initial screening thyroid hormone values and postnatal levothyroxine sodium dosage had an early predictive effect on clinical outcome in children with CH.
1、 KARA C, GUNINDI F, CAN YILMAZ G,et al. Transient congenital hypothyroidism in Turkey: an analysis on frequency and natural course[J].J Clin Res Pediatr Endocrinol,2016,8 (2): 170-179. KARA C, GUNINDI F, CAN YILMAZ G,et al. Transient congenital hypothyroidism in Turkey: an analysis on frequency and natural course[J].J Clin Res Pediatr Endocrinol,2016,8 (2): 170-179.
2、 ASENA M, DEMIRAL M, UNAL E, et al. Validity of six month l-thyroxine dose for differentiation of transient or permanent congenital hypothyroidism[J].J Clin Res Pediatr Endocrinol,2020,12 (3): 275-280. ASENA M, DEMIRAL M, UNAL E, et al. Validity of six month l-thyroxine dose for differentiation of transient or permanent congenital hypothyroidism[J].J Clin Res Pediatr Endocrinol,2020,12 (3): 275-280.
3、 SABA C, GUILMINCREPON S, ZENATY D, et al. Early determinants of thyroid function outcomes in children with congenital hypothyroidism and a normally located thyroid gland: a regional cohort study[J]. Thyroid, 2018,28(8):959-967. SABA C, GUILMINCREPON S, ZENATY D, et al. Early determinants of thyroid function outcomes in children with congenital hypothyroidism and a normally located thyroid gland: a regional cohort study[J]. Thyroid, 2018,28(8):959-967.
4、 ITONAGA T, HIGUCHI S, SHIMURA K, et al. Levothyroxine dosage as predictor of permanent and transient congenital hypothyroidism: a multicenter retrospective study in Japan [J]. Horm Res Paediat,2019,92(1): 45-51. ITONAGA T, HIGUCHI S, SHIMURA K, et al. Levothyroxine dosage as predictor of permanent and transient congenital hypothyroidism: a multicenter retrospective study in Japan [J]. Horm Res Paediat,2019,92(1): 45-51.
5、 ORON T, LAZAR L, BENYISHAI S,et al. Permanent vs transient congenital hypothyroidism: assessment of predictive variables[J]. J Clin Endocr Metab,2018,103(12): 4428-4436. ORON T, LAZAR L, BENYISHAI S,et al. Permanent vs transient congenital hypothyroidism: assessment of predictive variables[J]. J Clin Endocr Metab,2018,103(12): 4428-4436.
6、 HABIB A,SHOJAZADEH A, MOLAYEMAT M,et al. Prevalence and predictive factors of transient and permanent congenital hypothyroidism in Fars province, Iran [J].BMC Pediatr, 2021,21(6): 264. HABIB A,SHOJAZADEH A, MOLAYEMAT M,et al. Prevalence and predictive factors of transient and permanent congenital hypothyroidism in Fars province, Iran [J].BMC Pediatr, 2021,21(6): 264.
7、 范惠霞,高苗苗,阎亚琼,等. 先天性甲状腺功能减低症不同转归的早期预测因子探讨[J]. 中华全科医师杂志,2020,19(12):1141-1146. 范惠霞,高苗苗,阎亚琼,等. 先天性甲状腺功能减低症不同转归的早期预测因子探讨[J]. 中华全科医师杂志,2020,19(12):1141-1146.
8、 KANG M J, CHUNG H R, OH Y J,et al. Three-year follow-up of children with abnormal newborn screening results for congenital hypothyroidism. [J]. Pediatr Neonatol,2017,58(5): 442-448. KANG M J, CHUNG H R, OH Y J,et al. Three-year follow-up of children with abnormal newborn screening results for congenital hypothyroidism. [J]. Pediatr Neonatol,2017,58(5): 442-448.
9、 中华医学会儿科分会内分泌遗传代谢学组,中华预防医学会儿童保健分会新生儿筛查学组. 先天性甲状腺功能减低症诊疗共识[J].中华儿科杂志,2011,49(6):421-424. 中华医学会儿科分会内分泌遗传代谢学组,中华预防医学会儿童保健分会新生儿筛查学组. 先天性甲状腺功能减低症诊疗共识[J].中华儿科杂志,2011,49(6):421-424.
10、 赵正言,顾学范. 新生儿遗传代谢病筛查 [M]. 2版. 北京:人民卫生出版社,2015:131-132. 赵正言,顾学范. 新生儿遗传代谢病筛查 [M]. 2版. 北京:人民卫生出版社,2015:131-132.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录